Latest period
$1.33B
YoY change
+49.5%
5Y CAGR
-3.1%
Peak year (2021)
$1.83B
Latest annual
$1.36B
Free Cash Flow history chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: $1.36B
Free Cash Flow growth chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: +49.5%
Free Cash Flow history table for Quest Diagnostics (DGX) from 1996 to 2025
| 2025 | $1.36B | +49.5% | +$450.00M | ||
| 2024 | $909.00M | +5.2% | +$45.00M | ||
| 2023 | $864.00M | -34.2% | −$450.00M | ||
| 2022 | $1.31B | -28.2% | −$516.00M | ||
| 2021 | $1.83B | +15.3% | +$243.00M | ||
| 2020 | $1.59B | +88.3% | +$744.00M | ||
| 2019 | $843.00M | +3.2% | +$26.00M | ||
| 2018 | $817.00M | -11.5% | −$106.00M | ||
| 2017 | $923.00M | +18.9% | +$147.00M | ||
| 2016 | $776.00M | +41.9% | +$229.00M | ||
| 2015 | $547.00M | -13.2% | −$83.00M | ||
| 2014 | $630.00M | +49.6% | +$209.00M | ||
| 2013 | $421.00M | -58.1% | −$583.90M | ||
| 2012 | $1.00B | +36.9% | +$270.90M | ||
| 2011 | $734.00M | -19.6% | −$178.60M | ||
| 2010 | $912.60M | +9.9% | +$82.10M | ||
| 2009 | $830.50M | -2.3% | −$19.90M | ||
| 2008 | $850.40M | +20.1% | +$142.58M | ||
| 2007 | $707.82M | -6.7% | −$50.65M | ||
| 2006 | $758.47M | +20.9% | +$131.16M | ||
| 2005 | $627.31M | +0.7% | +$4.66M | ||
| 2004 | $622.65M | +27.6% | +$134.50M | ||
| 2003 | $488.16M | +10.6% | +$46.98M | ||
| 2002 | $441.18M | +39.3% | +$124.36M | ||
| 2001 | $316.82M | +25.2% | +$63.81M | ||
| 2000 | $253.00M | -129.7% | +$1.10B | ||
| 1999 | −$851.50M | -943.9% | −$952.40M | ||
| 1998 | $100.90M | -22.1% | −$28.60M | ||
| 1997 | $129.50M | -181.5% | +$288.38M | ||
| 1996 | −$158.88M | — | — |
- 2025$1.36B+49.5%
- 2024$909.00M+5.2%
- 2023$864.00M-34.2%
- 2022$1.31B-28.2%
- 2021$1.83B+15.3%
- 2020$1.59B+88.3%
- 2019$843.00M+3.2%
- 2018$817.00M-11.5%
- 2017$923.00M+18.9%
- 2016$776.00M+41.9%
- 2015$547.00M-13.2%
- 2014$630.00M+49.6%
- 2013$421.00M-58.1%
- 2012$1.00B+36.9%
- 2011$734.00M-19.6%
- 2010$912.60M+9.9%
- 2009$830.50M-2.3%
- 2008$850.40M+20.1%
- 2007$707.82M-6.7%
- 2006$758.47M+20.9%
- 2005$627.31M+0.7%
- 2004$622.65M+27.6%
- 2003$488.16M+10.6%
- 2002$441.18M+39.3%
- 2001$316.82M+25.2%
- 2000$253.00M-129.7%
- 1999−$851.50M-943.9%
- 1998$100.90M-22.1%
- 1997$129.50M-181.5%
- 1996−$158.88M—
Free Cash Flow values are taken from Quest Diagnostics's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Quest Diagnostics (DGX)
Free Cash Flow for Quest Diagnostics (DGX): headline value $1.33B · YoY +49.5%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Quest Diagnostics (DGX) free cash flow totalled $1.36B – surged 49.5% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Quest Diagnostics free cash flow compounded at -3.1% per year, sustaining 2 straight years of year-over-year growth.
Quest Diagnostics free cash flow peaked at $1.83B in 2021; the latest annual figure is $1.36B in 2025 (25.7% below peak).
Across the available history, free cash flow reached its high of $1.83B in 2021 and its low of −$851.50M in 1999.
Quest Diagnostics Free Cash Flow by Year
Quest Diagnostics Free Cash Flow 2025: $1.36B
Quest Diagnostics posted free cash flow of $1.36B in 2025, surged 49.5% from 2024.
Quest Diagnostics Free Cash Flow 2024: $909.00M
In 2024, Quest Diagnostics reported free cash flow of $909.00M, grew 5.2% from 2023.
Quest Diagnostics Free Cash Flow 2023: $864.00M
Quest Diagnostics free cash flow in 2023 was $864.00M, plunged 34.2% below 2022.
Quest Diagnostics Free Cash Flow 2022: $1.31B
2022's free cash flow for Quest Diagnostics came in at $1.31B, declined 28.2% below 2021.
Quest Diagnostics Free Cash Flow 2021: $1.83B
Quest Diagnostics free cash flow in 2021 was $1.83B.
See more financial history for Quest Diagnostics (DGX).
Sector peers by Free Cash Flow
Healthcare peers of Quest Diagnostics (DGX), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
Quest Diagnostics (DGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation